ALLOGENEIC-TUMOR REJECTION INDUCED BY THE INTRAVENOUS-INJECTION OF LYT-2+ CYTOLYTIC T-LYMPHOCYTE CLONES

[1] QUANTITATION AND CLONAL ISOLATION OF CYTOLYTIC LYMPHOCYTE-T PRECURSORS SELECTIVELY INFILTRATING MURINE SARCOMA VIRUS-INDUCED TUMORS [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (02) : 362 - 373

[2] BRUNNER KT, 1968, IMMUNOLOGY, V14, P181

[3] CARLSON GA, 1976, J IMMUNOL, V117, P822

[4] Carpenter C B, 1976, Adv Immunol, V22, P1, DOI 10.1016/S0065-2776(08)60547-7

[5] Cerottini J C, 1974, Adv Immunol, V18, P67, DOI 10.1016/S0065-2776(08)60308-9

[6] AUGMENTATION OF THE ANTI-TUMOR THERAPEUTIC EFFICACY OF LONG-TERM CULTURED LYMPHOCYTES-T BY INVIVO ADMINISTRATION OF PURIFIED INTERLEUKIN-2 [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (04) : 968 - 980

[7] REJECTION OF TUMOR ALLOGRAFTS BY MOUSE SPLEEN CELLS SENSITIZED IN-VITRO [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1971, 133 (04) : 821 - +

[8] DAILEY MO, 1982, J IMMUNOL, V128, P2134

[9] ENGERS HD, 1981, MECHANISMS LYMPHOCYT, P632

[10] ENGERS HD, 1982, J IMMUNOL

[1] QUANTITATION AND CLONAL ISOLATION OF CYTOLYTIC LYMPHOCYTE-T PRECURSORS SELECTIVELY INFILTRATING MURINE SARCOMA VIRUS-INDUCED TUMORS [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (02) : 362 - 373

[2] BRUNNER KT, 1968, IMMUNOLOGY, V14, P181

[3] CARLSON GA, 1976, J IMMUNOL, V117, P822

[4] Carpenter C B, 1976, Adv Immunol, V22, P1, DOI 10.1016/S0065-2776(08)60547-7

[5] Cerottini J C, 1974, Adv Immunol, V18, P67, DOI 10.1016/S0065-2776(08)60308-9

[6] AUGMENTATION OF THE ANTI-TUMOR THERAPEUTIC EFFICACY OF LONG-TERM CULTURED LYMPHOCYTES-T BY INVIVO ADMINISTRATION OF PURIFIED INTERLEUKIN-2 [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (04) : 968 - 980

[7] REJECTION OF TUMOR ALLOGRAFTS BY MOUSE SPLEEN CELLS SENSITIZED IN-VITRO [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1971, 133 (04) : 821 - +

[8] DAILEY MO, 1982, J IMMUNOL, V128, P2134

[9] ENGERS HD, 1981, MECHANISMS LYMPHOCYT, P632

[10] ENGERS HD, 1982, J IMMUNOL